Healthcare, economics and society – unlocking NHS collaboration

01/30/23 • 59 min

Pharma Market Access Insights - from Petauri Evidence

Will NHS leaders, as part of an Integrated Care System (ICS), make conscious decisions to drive economic and social change?
What social and economic value do ICSs offer the wider population they serve? How will industry support ICSs to deliver population-based health and social benefits?

Prof Phil Richardson (Chair and Chief Innovation Officer, Mtech Access) is joined by Michael Wood (Head of Health Economic Partnerships, NHS Confed) for a far-reaching discussion around system integration, population health management, and the NHS’s social and economic potential.
In December (2022), Michael Wood authored a report exploring one of the four key purposes of an ICS: to help the NHS support broader social and economic development. Michael’s NHS Confed report looked at the economics of healthcare and where broader strategic partnership working might lead system thinking in the NHS.
Phil Richardson was one of several experienced ICS, local authority, university and professional experts that Michael invited to share their perspectives in the report.
We were delighted to bring Michael and Phil together in this webinar to discuss these topics, particularly in light of what these new leadership purposes mean for the NHS’s relationship with the Pharmaceutical and wider Life Science industries.
In the webinar, Phil and Michael discuss:

NHS Confed and the links between the health sector and the economy
The need for ICS leaders to focus on broader social and economic development
How Pharma and Medical Device companies can add value to support this key ICS purpose
Why health and economic development is key to tackling health inequalities
The important role the NHS plays as an anchor institution that links better health with economic and social development
What health and economic development could mean for funding at different levels of an integrated system – e.g. place based commissioning
Opportunities for industry to step up and support the NHS with economic and social development

Learn more about this webinar here
Learn more about our work with the NHS
This episode was first broadcast as a live webinar in January 2023

Subscribe to our newsletter to hear more news, insights and events from Mtech Access.

NHS Confed and the links between the health sector and the economy
The need for ICS leaders to focus on broader social and economic development
How Pharma and Medical Device companies can add value to support this key ICS purpose
Why health and economic development is key to tackling health inequalities
The important role the NHS plays as an anchor institution that links better health with economic and social development
What health and economic development could mean for funding at different levels of an integrated system – e.g. place based commissioning
Opportunities for industry to step up and support the NHS with economic and social development

Learn more about this webinar here
Learn more about our work with the NHS
This episode was first broadcast as a live webinar in January 2023

Subscribe to our newsletter to hear more news, insights and events from Mtech Access.

Previous Episode

Specialised Commissioning in the NHS – What do you need to know now

The proposed new NHSE systems for specialised commissioning are arguably the highest risk of all current dynamics, both for the NHS and for suppliers. Key aspects or policy have been published in ways that are hard to access and even harder to interpret. Here, we gather an expert panel to discuss what proposed new NHSE systems for specialised commissioning mean in practice.
In this episode, we explore:
- What’s new for Specialised Commissioning and what’s set to change?
- What are the potential implications of the proposed changes recently published?
- Integrated Care Boards (ICBs) and their increasing role with Specialised Commissioning
- What this means for the NHS and for industry in practice
The episode begins with an overview and analysis of the changes from David Thorne (Principal Associate, Mtech Access and Business Development Director, Well Up North PCN). David then opens up a broader discussion about the implications of these changes with our guest panellists James Curtis (Deputy Operational Director, Gloucestershire NHS Foundation Trust) and Mohammed Asghar (ICS Prescribing Governance Lead at Frimley Health and Care ICS).
The episode was originally broadcast as a live webinar on 2nd December 2022.
Learn more at: https://mtechaccess.co.uk/specialised-commissioning-nhs/
Find our more about our NHS Insight and Interaction services

Subscribe to our newsletter to hear more news, insights and events from Mtech Access.

Next Episode

Innovating for better health – research, collaboration and innovation in the NHS

How and where can innovation drive improvements in care and deliver better health for the population?
How is the NHS looking to collaborate with key partners across industry and academia? What innovations are set to transform care? What role do Academic Health Science Networks (AHSNs) play and how can partners best engage with them?
Prof Phil Richardson (Chair and Chief Innovation Officer, Mtech Access) is joined by Bill Gillespie (Chief Executive Officer, Wessex AHSN) to explore innovation in the NHS, the role of AHSNs and the potential for greater collaboration across our sector, in our latest NHS Whispers webinar.
Learn more at: https://mtechaccess.co.uk/innovating-for-better-health/
The episode was was originally broadcast as a live webinar on 24th February 2023.
Discover our NHS Insights services and how we can support Medtech innovations achieve market access.

Subscribe to our newsletter to hear more news, insights and events from Mtech Access.

Pharma Market Access Insights - from Petauri Evidence - Healthcare, economics and society – unlocking NHS collaboration

Transcript

00:00:00.719

- [Narrator] Welcome to this Mtech Access webinar. At Mtech Access, we provide health economic and outcomes research and market access services from strategy through to implementation.

00:00:14.279

Our unique NHS relationships guide and validate everything we do in the UK. We work with over 80 NHS Associates to bring our Pharmaceutical and Medtech clients authentic insights into the NHS. We can help you answer key questions related to the NHS, from